Monitoring and Support for Patients Receiving CAR T-Cell Therapy
Experts discuss providing supportive care to patients receiving CAR T-cell therapy.
Experts Discuss Second-line Transplant and CAR T-Cell Therapy for DLBCL
Leo I. Gordon, MD, and others discussed second-line treatment of diffuse large B-cell lymphoma.
Dr. Gordon on the Concerns of CAR T-Cell Therapy
Leo I. Gordon, MD, professor of medicine, Feinberg School of Medicine, Northwestern University, discusses the concerns of chimeric antigen receptor (CAR) T-cell therapy.